UNCOMMON? PHARMACEUTICAL INTERVENTIONS: HYPOMAGNESEMIA AND PROTON PUMP INHIBITORS

• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Poster
• Poster code: POS-HPS-038
• By: DOMINGUEZ BARAHONA, Ana (Hospital Virgen de la Salud, Hospitalary Pharmacy, Spain)
• Co-author(s): Ana Dominguez Barahona: Hospitalary Pharmacy, Hospital Virgen de la Salud, Toledo, Spain
  Manuela Martinez Camacho: Hospitalary Pharmacy, Hospital Virgen de la Salud, Toledo, Spain
  Ana Garcia Sacristán: Hospitalary Pharmacy, Hospital Virgen de la Salud, Toledo, Spain
  Silvia Gonzalez Suarez: Hospitalary Pharmacy, Hospital Virgen de la Salud, Toledo, Spain
  Raúl López Álvarez: Hospitalary Pharmacy, Hospital Virgen de la Salud, Toledo, Spain
  David Garcia Marco: Hospitalary Pharmacy, Hospital Nacional de Paraplejicos, Toledo, Spain
  Encarnación Rodriguez Jimenez: Hospitalary Pharmacy, Hospital Virgen de la Salud, Toledo, Spain
  Aída Rueda Naharro: Hospitalary Pharmacy, Hospital Nacional de Paraplejicos, Toledo, Spain
  Antonia Santos Azorín: Pharmacovigilance department, Conserjeria Sanidad, Toledo, Spain
  
• Abstract:

  Background

  Pharmaceutical interventions are actions carried out by the pharmacist for the improvement of patient therapy. Hypomagnesemia is an adverse effect associated with the use of proton pump inhibitors (PPIs).

  Methods

  Retrospective study of three months (January-March 2019), carried out in a Geriatric Acute Hospital. The interventions
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login